Menu
Menu
Menu

Stock shortages

Search Results

Stock shortages

On this page, you will find an overview of medicines (temporarily) unavailable in Belgium that are relevant to a patient suffering from heart failure.
The table below also indicates the likely duration of unavailability and suggests possible alternatives.

This page is regularly updated, but may occasionally not be completely up to date.
The full list of medicines unavailable in Belgium can be consulted at the following address: FarmaStatus

Medicine not available

Estimated duration

Alternatives

Onbeschikbaar geneesmiddel

Xarelto 10 mg, 15 mg and 20 mg are no longer reimbursed in Belgium since 01-09-2024.

Xarelto 2.5 mg will continue to be reimbursed as before.

Vermoedelijk duur

Indefinite

Alternatieven
  • One of the generics Rivaroxaban. If there is already a current reimbursement for Xarelto, no new application should be made.
  • Another DOAC (apixaban, edoxaban or dabigatran). After stopping the reimbursement of Xarelto in CIVARS, a new application must be made, starting the following day, for the other DOAC.
crossmenu